Cardiometabolic Care: Assessing Patients with Diabetes Mellitus with No Overt Cardiovascular Disease in the Light of Heart Failure Development Risk.
Christina ChrysohoouChristos FragoulisIoannis LeontsinisIoannis GastouniotisDimitra FragouliMaximos GeorgopoulosEmmanouil MantzouranisMarina NoutsouKonstantinos P TsioufisPublished in: Nutrients (2023)
The mechanisms leading to the development of heart failure (HF) in diabetes mellitus (DM) patients are multifactorial. Assessing the risk of HF development in patients with DM is valuable not only for the identification of a high-risk subgroup, but also equally important for defining low-risk subpopulations. Nowadays, DM and HF have been recognized as sharing similar metabolic pathways. Moreover, the clinical manifestation of HF can be independent of LVEF classification. Consequently, approaching HF should be through structural, hemodynamic and functional evaluation. Thus, both imaging parameters and biomarkers are important tools for the recognition of diabetic patients at risk of HF manifestation and HF phenotypes, and arrhythmogenic risk, and eventually for prognosis, aiming to improve patients' outcomes utilizing drugs and non-pharmaceutical cardioprotective tools such as diet modification.
Keyphrases
- heart failure
- acute heart failure
- end stage renal disease
- cardiovascular disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- healthcare
- palliative care
- atrial fibrillation
- randomized controlled trial
- high resolution
- machine learning
- clinical trial
- physical activity
- coronary artery disease
- photodynamic therapy
- health insurance
- social media
- cardiovascular risk factors
- health information